Zobrazeno 1 - 10
of 13 685
pro vyhledávání: '"IgA-nephropathy"'
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Objective The aim of this study was to investigate the prognostic value of mesangial IgM deposition in a long-term follow-up cohort of patients with immunoglobulin A nephropathy (IgAN). Methods A retrospective analysis of clinicopathological
Externí odkaz:
https://doaj.org/article/f2028b08607d4f669f45eaf2b2c81853
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 9269-9283 (2024)
Sen-Qing Lin,* Jin-Xiu Deng,* Hui Jiang, Shi-Hong Xiang, Wen-Jing Lin, Feng-Qi Qian, Sen-Chao Wu, Fu-Zhen Wang Department of Nephrology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, People’s Republic of China&ast
Externí odkaz:
https://doaj.org/article/df355ec359a2423d87916a08677aab25
Autor:
Jin Sug Kim, Geon Woo Kim, Hyeon Seok Hwang, Yang Gyun Kim, Ju-Young Moon, Sang Ho Lee, Junhee Seok, Donghyun Tae, Kyung Hwan Jeong
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background The quantification of mRNA expression in urinary sediments is a reliable biomarker for various diseases. However, few studies have investigated the clinical relevance of urinary mRNA levels in IgA nephropathy (IgAN). Thus, we inve
Externí odkaz:
https://doaj.org/article/2c90376192e042268136855fa9547577
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Introduction The role of complement system in late stage of IgA nephropathy (IgAN) remains unknown. We therefore investigated the effects of complement system on worsening kidney function in advanced (stage 4 CKD) IgAN. Methods Renal specime
Externí odkaz:
https://doaj.org/article/a3a8a9e6d16c4814aba916bf9776c01c
Autor:
Hyeon Tae Yang, Tae In Park, Yong-Jin Kim, Mee-seon Kim, Sun-Hee Park, Jeong-Hoon Lim, Yoo Na Kang, DongJa Kim, Man-Hoon Han
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Immunoglobulin A nephropathy (IgAN) is the predominant primary glomerulonephritis globally and remains a subject of active research with a focus on understanding its course and prognosis. Although vascular lesions are associated w
Externí odkaz:
https://doaj.org/article/397dd83bac6948e4823554dd5019f309
Autor:
Wenqiang Zhi, Aizhong Li, Qian Wang, Xiaoli Yuan, Jianbo Qing, Caixiang Zhang, Yuxin Wang, Yafeng Li
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract To assess the safety and efficacy of fecal microbiota transplantation (FMT) as an adjunctive therapeutic intervention for IgA nephropathy (IgAN). Fifteen patients with IgA nephropathy were recruited based on inclusion and exclusion criteria
Externí odkaz:
https://doaj.org/article/b3a395dbd47549cd862edebf1bf22dad
Publikováno v:
Linchuang shenzangbing zazhi, Vol 24, Iss 10, Pp 878-880 (2024)
Externí odkaz:
https://doaj.org/article/ac720919960d43579e4a0752f6f37f13
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-6 (2024)
Abstract Background Behcet’s disease (BD) is an inflammatory disorder of unknown cause that is characterized by recurrent oral aphthous ulcers, genital ulcers, uveitis, and skin lesions. Local vasculitis can cause damage to the visceral system, but
Externí odkaz:
https://doaj.org/article/56cc8c7c1a6e4572b9058828641c760b
Autor:
Ahmed A. Abo Elnaga, Mohamed A. Alsaied, Abdelrahman M. Elettreby, Alaa Ramadan, Mohamed Abouzid, Raghda Shetta, Yazan A. Al-Ajlouni
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Sparsentan has shown positive effects on managing different subtypes of glomerulonephritis. The recent results of trials require a pooled analysis to validate these results. Aim We aim to assess the safety and efficacy of sparsent
Externí odkaz:
https://doaj.org/article/6b443702776f4154a5a2dc579fbf8135